Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Endo Health Solutions Inc    ENDP

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Senate Panel Seeks Info From J&J, Endo, Others Over Concern On Painkiller Marketing -Reuters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/09/2012 | 08:44pm CET

The Senate Finance Committee is looking into possible links between three drug companies and nonprofit medical groups, citing concerns about the groups' advocacy of painkillers, Reuters reported Wednesday.

The panel sent letters to Johnson & Johnson (JNJ), Endo Pharmaceuticals Holdings Inc. (>> Endo Pharmaceuticals Holdings Inc) and Purdue Pharma LP and seven medical groups seeking documents about their financial connections, Reuters reported.

Sen. Max Baucus (D., Mont.), the committee's chairman, said in a statement that "painkillers have an important role in health care when prescribed and used properly, but pushing misinformation on consumers to boost profits is not only wrong, it's dangerous," Reuters reported.

Reuters said officials at the three drug companies weren't immediately available for comment.

Full story at http://www.reuters.com/article/2012/05/09/us-usa-painkillers-investigation-idUSBRE84811420120509

-Dow Jones Newswires; 212-416-2900

Stocks mentioned in the article : Endo Pharmaceuticals Holdings Inc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ENDO HEALTH SOLUTIONS INC
11/29 ENDO INTERNATIONAL PLC : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of..
11/24 ENDO INTERNATIONAL PLC : Bronstein, Gewirtz & Grossman, LLC Notifies Investors o..
11/04 ENDO INTERNATIONAL PLC : Bronstein, Gewirtz & Grossman, LLC Announces Investigat..
11/04 EXCLUSIVE : Endo considers sale of Paladin Labs to Knight Therapeutics - sources
11/04 Drugmakers under fire for possible U.S. price fixing
11/03ENDO INTERNATIONAL PLC : quaterly earnings release
10/03 DRUG MAKER CONCORDIA IN TALKS TO SEL : sources
09/26 ENDO INTERNATIONAL PLC : Blog Coverage Change in Leadership at Endo Pharma
09/23 Endo International CEO steps down, Campanelli named successor
08/09DJU.S. HOT STOCKS : Hot Stocks to Watch
More news
Sector news : Generic Pharmaceuticals
12/07 MYLAN : EpiPen maker Mylan to restructure, cut workforce
12/07DJABBOTT LABORATORIES : Seeks to Terminate Alere Deal -- Update
12/07DJPFIZER : Fined $107 Million for Overcharging U.K. for Epilepsy Drug
12/07DJABBOTT LABORATORIES : Seeks to Terminate Alere Deal
12/07DJMARKET SNAPSHOT : Dow, S&P 500 Set Intraday Records, But Health-care Slumps On T..
More sector news : Generic Pharmaceuticals
Advertisement
Financials ($)
Sales 2016 3 931 M
EBIT 2016 1 484 M
Net income 2016 342 M
Debt 2016 7 956 M
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017 9,09
EV / Sales 2016 2,92x
EV / Sales 2017 2,71x
Capitalization 3 535 M
More Financials
Technical analysis trends ENDO HEALTH SOLUT...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 23,6 $
Spread / Average Target 49%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Paul V. Campanelli President, Chief Executive Officer & Director
Roger H. Kimmel Chairman
Terrance J. Coughlin Chief Operating Officer & Executive Vice President
Blaise Coleman Chief Financial Officer
Robert J. Cobuzzi SVP-Operations, Research & Development Strategy
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ENDO HEALTH SOLUTIONS ..3 535
SUN PHARMACEUTICAL IND..-12.71%24 965
OTSUKA HOLDINGS CO LTD4.59%21 906
ONO PHARMACEUTICAL CO...-44.11%12 500
ASPEN PHARMACARE HOLDI..-10.55%9 122
SHANGHAI FOSUN PHARMAC..-2.51%7 994
More Results